Published in J Nucl Med on May 01, 2000
The management of painful bone metastases with an emphasis on radionuclide therapy. J Natl Med Assoc (2007) 1.55
Radionuclide Therapy of Bone Metastases. Breast Care (Basel) (2012) 1.09
Hemopoietic response to low dose-rates of ionizing radiation shows stem cell tolerance and adaptation. Dose Response (2012) 1.03
Patient exposures and consequent risks from nuclear medicine procedures. Health Phys (2011) 0.77
Autotrophic picoplankton in the tropical ocean. Science (1983) 4.80
Inhibitory Effect of Water on Oxygen Consumption by Plant Materials. Plant Physiol (1960) 3.60
ICRP Publication 116. Conversion coefficients for radiological protection quantities for external radiation exposures. Ann ICRP (2012) 2.59
MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med (1999) 2.41
Sugar consumption and cigarette smoking. Lancet (1970) 2.22
Free radical-initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model. Radiat Res (2001) 1.90
Detection of lung cancer in a male industrial population. Br J Prev Soc Med (1967) 1.90
Disease coding by computer. The "fruit machine" method. Br J Prev Soc Med (1968) 1.82
Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model. Radiat Res (1999) 1.62
Smoking habits and laboratory tests. Lancet (1970) 1.59
Automatic disease coding: the 'fruit-machine' method in general practice. Br J Prev Soc Med (1973) 1.57
Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions. J Nucl Med (2000) 1.55
Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides. J Nucl Med (1993) 1.53
Relative biological effectiveness of alpha-particle emitters in vivo at low doses. Radiat Res (1994) 1.53
MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.44
Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys (1985) 1.44
The impact of recirculating industrial air on aircraft painting operations. Appl Occup Environ Hyg (1999) 1.40
Lung cancer prognosis and routine radiography. Br J Prev Soc Med (1968) 1.38
The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells. Radiat Res (1991) 1.30
Variability in audiometric recording. Br J Ind Med (1972) 1.29
Further evaluation of the Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry (1970) 1.28
A new rectal model for dosimetry applications. J Nucl Med (1999) 1.23
Phosphorus Tolerance and Sensitivity of Soybeans as Related to Uptake and Translocation. Plant Physiol (1964) 1.22
Health workers in the United Kingdom Atomic Energy Authority. Health Phys (1970) 1.18
Response functions for computing absorbed dose to skeletal tissues from photon irradiation. Radiat Prot Dosimetry (2008) 1.16
Tissue-equivalent materials for construction of tomographic dosimetry phantoms in pediatric radiology. Med Phys (2003) 1.14
Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors. Med Phys (1989) 1.11
Protection by DMSO against cell death caused by intracellularly localized iodine-125, iodine-131 and polonium-210. Radiat Res (2000) 1.10
Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J Nucl Med (1994) 1.10
In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles. Lancet (1989) 1.09
Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J Nucl Med (1994) 1.09
Radioprotection against lethal damage caused by chronic irradiation with radionuclides in vitro. Radiat Res (1998) 1.09
Dietary sugar and ischaemic heart disease. Br Med J (1969) 1.09
NMR microscopy of trabecular bone and its role in skeletal dosimetry. Health Phys (1998) 1.08
MIRD Pamphlet No. 15: Radionuclide S values in a revised dosimetric model of the adult head and brain. Medical Internal Radiation Dose. J Nucl Med (1999) 1.05
Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides. J Nucl Med (1994) 1.04
Induction of sperm head abnormalities by incorporated radionuclides: dependence on subcellular distribution, type of radiation, dose rate, and presence of radioprotectors. Radiat Res (1991) 1.04
The MIRD perspective 1999. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.03
Biological consequence of nuclear versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger cascades in vivo. Radiat Res (1990) 1.02
Individual variations in mucosa and total wall thickness in the stomach and rectum assessed via endoscopic ultrasound. Physiol Meas (2003) 1.02
New cladiellane diterpenes from the soft coral Cladiella australis of the Andaman and Nicobar Islands. J Nat Prod (1994) 1.01
Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides. Radiat Res (1994) 1.01
Marching cube algorithm: review and trilinear interpolation adaptation for image-based dosimetric models. Comput Med Imaging Graph (2003) 1.00
Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med Phys (1994) 1.00
Anti-inflammatory effect of human placental extract: a biochemical mechanistic approach. Riv Eur Sci Med Farmacol (1993) 0.99
Subject variability in short-term audiometric recording. Br J Ind Med (1973) 0.98
Creation of two tomographic voxel models of paediatric patients in the first year of life. Phys Med Biol (2002) 0.98
Inhaled ozone as a mutagen. I. Chromosome aberrations induced in Chinese hamster lymphocytes. Environ Res (1971) 0.97
Vitamin C as a radioprotector against iodine-131 in vivo. J Nucl Med (1993) 0.96
Voxel-based models representing the male and female ICRP reference adult--the skeleton. Radiat Prot Dosimetry (2007) 0.96
Sugar and ischemic heart disease. Br Med J (1969) 0.95
A seven-year review of measured hearing levels in male manual steelworkers with high initial thresholds. Br J Ind Med (1978) 0.95
Simple isolation of polonium-210 from silver. Appl Radiat Isot (1994) 0.94
Five pediatric head and brain mathematical models for use in internal dosimetry. J Nucl Med (1999) 0.94
[125I/127I]iodoHoechst 33342: synthesis, DNA binding, and biodistribution. J Med Chem (1996) 0.94
Height, weight and obesity in an industrial population. Trans Assoc Ind Med Off (1965) 0.93
Social class and biological tests. Lancet (1970) 0.93
Sickness absence levels and personality inventory scores. Br J Ind Med (1971) 0.93
Cytotoxicity of some indium radiopharmaceuticals in mouse testes. J Nucl Med (1988) 0.92
Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design. J Nucl Med (1992) 0.91
Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo. Radiat Res (1997) 0.90
S values for radionuclides localized within the skeleton. J Nucl Med (2000) 0.90
Crystalline principles from the leaves and twigs of Leptadenia reticulata. Planta Med (1975) 0.90
Improvement of internal dose calculations using mathematical models of different adult heights. Phys Med Biol (2000) 0.89
Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med (1983) 0.89
Beta-carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. Br J Cancer (1997) 0.89
Design and performance characteristics of an experimental cesium-137 irradiator to simulate internal radionuclide dose rate patterns. J Nucl Med (1997) 0.89
Obesity and smoking habits. Br Med J (1971) 0.88
Radioprotection by DMSO against the biological effects of incorporated radionuclides in vivo--Comparison with other radioprotectors and evidence for indirect action of Auger electrons. Acta Oncol (1996) 0.88
Bystander responses in three-dimensional cultures containing radiolabelled and unlabelled human cells. Radiat Prot Dosimetry (2006) 0.88
Vitamins as radioprotectors in vivo. I. Protection by vitamin C against internal radionuclides in mouse testes: implications to the mechanism of damage caused by the Auger effect. Radiat Res (1994) 0.88
Generalized approach to absorbed dose calculations for dynamic tumor and organ masses. J Nucl Med (1995) 0.87
Comparative cost analysis of hemilaryngectomy and irradiation for early glottic carcinoma. Int J Radiat Oncol Biol Phys (1983) 0.87
Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters. Radiat Res (1994) 0.87
Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells. Radiat Res (1994) 0.87
Testicular and plasma ascorbic acid levels in mice following dietary intake: a high-performance liquid chromatographic analysis. J Chromatogr (1993) 0.86